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Author’s reply:
Considering the brief case description of Shiihara and
Takahashi [6], we agree on the diagnosis of opsoclonus–
myoclonus syndrome (OMS) following an infection with
Mycoplasma pneumoniae although “jerky movements” are
difficult to distinguish from a cerebellar ataxia.
The presence of autoantibodies against glutamate recep-
tors (GluR) rises the question whether the consciousness of
the patient was affected or not [2], which is important for
the diagnosis of a possible encephalitis. Besides, it may be
crucial to rule out other tumors than neuroblastoma, e.g.,
teratomas and carcinomas [1].
The normal findings of the cerebrospinal fluid (CSF)
examination without either pleocytosis or positive anti-
bodies on day 30 are surprising. This contrasts with other
published cases of autoimmune encephalitis with positive
anti-GluR-delta2 antibodies [4, 5].
One of the main messages of our communication in this
journal was the need for a prompt treatment with cortico-
steroids starting in the first week of disease manifestation
[3]. This was also described in cases of anti-GluR-delta2
antibody-positive encephalitis [7]. Intravenous immunoglo-
bulins may have a place as a second line therapy. One can
speculate that the extended course described by Shiihara
and Takahashi may be the result of a delay in therapy.
Given the lack of remaining CSF or serum in our three
patients, we cannot contribute to the question whether anti-
GluR-delta2 antibodies are pathognomonic for OMS
following an infection with M. pneumoniae. However, we
would encourage the detection of anti-GluR-delta2 anti-
bodies in serum and CSF in future cases of OMS following
an infection with M. pneumoniae to further elucidate the
role of these antibodies.
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